Cargando…

Defining the architecture of KPC-2 Carbapenemase: identifying allosteric networks to fight antibiotics resistance

The rise of multi-drug resistance in bacterial pathogens is one of the grand challenges facing medical science. A major concern is the speed of development of β-lactamase-mediated resistance in Gram-negative species, thus putting at risk the efficacy of the most recently approved antibiotics and inh...

Descripción completa

Detalles Bibliográficos
Autores principales: Galdadas, Ioannis, Lovera, Silvia, Pérez-Hernández, Guillermo, Barnes, Melissa D., Healy, Jess, Afsharikho, Hamidreza, Woodford, Neil, Bonomo, Robert A., Gervasio, Francesco L., Haider, Shozeb
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110804/
https://www.ncbi.nlm.nih.gov/pubmed/30150677
http://dx.doi.org/10.1038/s41598-018-31176-0
_version_ 1783350540663521280
author Galdadas, Ioannis
Lovera, Silvia
Pérez-Hernández, Guillermo
Barnes, Melissa D.
Healy, Jess
Afsharikho, Hamidreza
Woodford, Neil
Bonomo, Robert A.
Gervasio, Francesco L.
Haider, Shozeb
author_facet Galdadas, Ioannis
Lovera, Silvia
Pérez-Hernández, Guillermo
Barnes, Melissa D.
Healy, Jess
Afsharikho, Hamidreza
Woodford, Neil
Bonomo, Robert A.
Gervasio, Francesco L.
Haider, Shozeb
author_sort Galdadas, Ioannis
collection PubMed
description The rise of multi-drug resistance in bacterial pathogens is one of the grand challenges facing medical science. A major concern is the speed of development of β-lactamase-mediated resistance in Gram-negative species, thus putting at risk the efficacy of the most recently approved antibiotics and inhibitors, including carbapenems and avibactam, respectively. New strategies to overcome resistance are urgently required, which will ultimately be facilitated by a deeper understanding of the mechanisms that regulate the function of β-lactamases such as the Klebsiella Pneumoniae carbapenemases (KPCs). Using enhanced sampling computational methods together with site-directed mutagenesis, we report the identification of two “hydrophobic networks” in the KPC-2 enzyme, the integrity of which has been found to be essential for protein stability and corresponding resistance. Present throughout the structure, these networks are responsible for the structural integrity and allosteric signaling. Disruption of the networks leads to a loss of the KPC-2 mediated resistance phenotype, resulting in restored susceptibility to different classes of β-lactam antibiotics including carbapenems and cephalosporins. The ”hydrophobic networks” were found to be highly conserved among class-A β-lactamases, which implies their suitability for exploitation as a potential target for therapeutic intervention.
format Online
Article
Text
id pubmed-6110804
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-61108042018-08-30 Defining the architecture of KPC-2 Carbapenemase: identifying allosteric networks to fight antibiotics resistance Galdadas, Ioannis Lovera, Silvia Pérez-Hernández, Guillermo Barnes, Melissa D. Healy, Jess Afsharikho, Hamidreza Woodford, Neil Bonomo, Robert A. Gervasio, Francesco L. Haider, Shozeb Sci Rep Article The rise of multi-drug resistance in bacterial pathogens is one of the grand challenges facing medical science. A major concern is the speed of development of β-lactamase-mediated resistance in Gram-negative species, thus putting at risk the efficacy of the most recently approved antibiotics and inhibitors, including carbapenems and avibactam, respectively. New strategies to overcome resistance are urgently required, which will ultimately be facilitated by a deeper understanding of the mechanisms that regulate the function of β-lactamases such as the Klebsiella Pneumoniae carbapenemases (KPCs). Using enhanced sampling computational methods together with site-directed mutagenesis, we report the identification of two “hydrophobic networks” in the KPC-2 enzyme, the integrity of which has been found to be essential for protein stability and corresponding resistance. Present throughout the structure, these networks are responsible for the structural integrity and allosteric signaling. Disruption of the networks leads to a loss of the KPC-2 mediated resistance phenotype, resulting in restored susceptibility to different classes of β-lactam antibiotics including carbapenems and cephalosporins. The ”hydrophobic networks” were found to be highly conserved among class-A β-lactamases, which implies their suitability for exploitation as a potential target for therapeutic intervention. Nature Publishing Group UK 2018-08-27 /pmc/articles/PMC6110804/ /pubmed/30150677 http://dx.doi.org/10.1038/s41598-018-31176-0 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Galdadas, Ioannis
Lovera, Silvia
Pérez-Hernández, Guillermo
Barnes, Melissa D.
Healy, Jess
Afsharikho, Hamidreza
Woodford, Neil
Bonomo, Robert A.
Gervasio, Francesco L.
Haider, Shozeb
Defining the architecture of KPC-2 Carbapenemase: identifying allosteric networks to fight antibiotics resistance
title Defining the architecture of KPC-2 Carbapenemase: identifying allosteric networks to fight antibiotics resistance
title_full Defining the architecture of KPC-2 Carbapenemase: identifying allosteric networks to fight antibiotics resistance
title_fullStr Defining the architecture of KPC-2 Carbapenemase: identifying allosteric networks to fight antibiotics resistance
title_full_unstemmed Defining the architecture of KPC-2 Carbapenemase: identifying allosteric networks to fight antibiotics resistance
title_short Defining the architecture of KPC-2 Carbapenemase: identifying allosteric networks to fight antibiotics resistance
title_sort defining the architecture of kpc-2 carbapenemase: identifying allosteric networks to fight antibiotics resistance
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110804/
https://www.ncbi.nlm.nih.gov/pubmed/30150677
http://dx.doi.org/10.1038/s41598-018-31176-0
work_keys_str_mv AT galdadasioannis definingthearchitectureofkpc2carbapenemaseidentifyingallostericnetworkstofightantibioticsresistance
AT loverasilvia definingthearchitectureofkpc2carbapenemaseidentifyingallostericnetworkstofightantibioticsresistance
AT perezhernandezguillermo definingthearchitectureofkpc2carbapenemaseidentifyingallostericnetworkstofightantibioticsresistance
AT barnesmelissad definingthearchitectureofkpc2carbapenemaseidentifyingallostericnetworkstofightantibioticsresistance
AT healyjess definingthearchitectureofkpc2carbapenemaseidentifyingallostericnetworkstofightantibioticsresistance
AT afsharikhohamidreza definingthearchitectureofkpc2carbapenemaseidentifyingallostericnetworkstofightantibioticsresistance
AT woodfordneil definingthearchitectureofkpc2carbapenemaseidentifyingallostericnetworkstofightantibioticsresistance
AT bonomoroberta definingthearchitectureofkpc2carbapenemaseidentifyingallostericnetworkstofightantibioticsresistance
AT gervasiofrancescol definingthearchitectureofkpc2carbapenemaseidentifyingallostericnetworkstofightantibioticsresistance
AT haidershozeb definingthearchitectureofkpc2carbapenemaseidentifyingallostericnetworkstofightantibioticsresistance